UK Housebuilding Sector in 2018: Stick and Reasons

Hardman & Co

Hardman & Co Report Report Downloads‘From the deserts of East Ham to the gardens of Cottenham’, the UK Housebuilding Sector was whacked to the tune of 27% in 2018; and not one share price (out of 18) rose on the London Stock Exchange.

It was also hit ‘slowly’ rather than ‘quick’, as the downward momentum gathered tempo, with 4Q (minus 16%) being the worst.

“Ow”, as the late, great Ian Dury (1942-2000) sang in one of his most famous songs (and his sole number one): ‘Hit me with your Rhythm Stick’.

But his was/and is a capricious business, just like housebuilding. For example, from 252 trading days in 2018, 52% were ‘up’ and 48% were ‘down’. Similarly, the maximum rise and fall in a single day was plus 5.0% and minus 6.3%, respectively.

But there are ‘Reasons to be Cheerful’, too, and for Mr Dury they came in threes – “a bit of grin and bear it, a bit of come and share it. You’re welcome we can spare it”. He was one of few true originals of the English music scene.

And UK Housebuilding can also enjoy its own jocund, musical treble, even with the dissonance of an off-key No-Deal-Brexit Big Bopper:

1: December was the only month in 4Q to see a rise in value (+1%), the nine-day trading period over Christmas added a further 2.2% and then the first four trading days of 2019 plus 3.2%;

2: earnings are to be flat, based on a consensus of forecasts, in 2019 but will increase (at least) 5% next year; and

3: a prospective yield of 7%.

2018: the Sector has had its worst year.

Share on:
Find more news, interviews, share price & company profile here for:

    HUTCHMED showcases new oncology data at ASCO 2025

    HUTCHMED (China) Limited is set to unveil groundbreaking data on key cancer therapies at the 2025 ASCO Annual Meeting, highlighting promising advancements in NSCLC and solid tumors.

    Ilika launches £3.8m fundraise including £0.5m Retail Offer

    Ilika Plc has successfully closed its accelerated bookbuild, raising approximately £3.3 million to enhance solid-state battery technology and commercial growth.

    Nuformix raises £210,000 to advance NXP002 and US Orphan Drug Application

    Nuformix plc (LON:NFX) aims to raise £210,000 through a conditional placing to advance its NXP002 inhalation treatment for IPF and PPF.

    Likewise grants over 3.1m shares under 2025 SAYE scheme

    Likewise Group plc (LON:LIKE) has successfully closed its 2025 Save As You Earn Scheme, granting options to 69 employees on over 3.1 million shares.

    Zotefoams reports record £50.7m revenue in strong start to 2025

    Zotefoams Plc reports strong sales growth of 8% and record revenue for the first four months of 2025, showcasing a successful strategic pivot into key markets.

    Ilika announces £3.5m fundraise via Placing and Retail Offer

    Ilika Plc, a leader in solid-state battery technology, plans to raise approximately £3.0 million through a new share placing and a retail offer for shareholders.

      Search

      Search